Disrupting the PCSK9/LDLR protein-protein interaction by an imidazole-based minimalist peptidomimetic.

Herein we report on the multicomponent synthesis of a novel imidazole-based compound, able to act efficiently as a minimalist β-strand mimic. Biological evaluation proved its ability to impair the LDLR-PCSK9 protein-protein interaction, disclosing it as the first small molecule exerting a PCSK9-mediated hypocholesterolemic effect.

[1]  Jean-Luc Poyet,et al.  Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology , 2014, Molecular informatics.

[2]  A. Hamilton,et al.  A Modular Synthesis of Conformationally Preorganised Extended β-Strand Peptidomimetics. , 2015, Chemistry.

[3]  A. Iskandrian,et al.  Major risk factors for cardiovascular disease: debunking the "only 50%" myth. , 2003, JAMA.

[4]  Erinna F. Lee,et al.  Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain. , 2012, Journal of the American Chemical Society.

[5]  Pauline N. Wyrembak,et al.  Alkyne-linked 2,2-disubstituted-indolin-3-one oligomers as extended beta-strand mimetics. , 2009, Journal of the American Chemical Society.

[6]  G. Verdine,et al.  Stapled peptides for intracellular drug targets. , 2012, Methods in enzymology.

[7]  Hyun Pyo Kim,et al.  1,5-Diarylimidazoles with strong inhibitory activity against COX-2 catalyzed PGE2 production from LPS-induced RAW 264.7 cells. , 2010, Bioorganic & medicinal chemistry letters.

[8]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[9]  Kevin Burgess,et al.  Minimalist and universal peptidomimetics. , 2011, Chemical Society reviews.

[10]  J. D. Del Valle,et al.  Substituted imidazo[1,2-a]pyridines as β-strand peptidomimetics. , 2012, Organic letters.

[11]  Nathan T. Ross,et al.  Synthetic mimetics of protein secondary structure domains , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[12]  C. Lammi,et al.  Lupin Peptides Modulate the Protein-Protein Interaction of PCSK9 with the Low Density Lipoprotein Receptor in HepG2 Cells , 2016, Scientific Reports.

[13]  A. Hamilton,et al.  A 1,3-phenyl-linked hydantoin oligomer scaffold as a β-strand mimetic. , 2012, Chemical communications.

[14]  Pedro A Fernandes,et al.  Hot spots—A review of the protein–protein interface determinant amino‐acid residues , 2007, Proteins.

[15]  S. Jones,et al.  Principles of protein-protein interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Kim D Janda,et al.  Protein-protein interactions and cancer: targeting the central dogma. , 2011, Current topics in medicinal chemistry.

[17]  Ralph Hirschmann,et al.  Design, synthesis, and crystal structure of a pyrrolinone-based peptidomimetic possessing the conformation of a .beta.-strand: potential application to the design of novel inhibitors of proteolytic enzymes , 1992 .

[18]  Wei Li,et al.  Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor , 2013, The Journal of Biological Chemistry.

[19]  D. Fairlie,et al.  Beta-strand mimetics. , 2004, Chemical reviews.

[20]  E. Gillies,et al.  Amphipathic beta-strand mimics as potential membrane disruptive antibiotics. , 2009, The Journal of organic chemistry.

[21]  Lamberth Clemens,et al.  チュブリン重合促進因子の合成と真菌殺傷活性 パート3:イミダゾール類 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター , 2013 .

[22]  Ralph Hirschmann,et al.  De Novo Design, Synthesis, and X-ray Crystal Structures of Pyrrolinone-Based .beta.-Strand Peptidomimetics , 1994 .

[23]  Jonathan C. Cohen,et al.  Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation* , 2007, Journal of Biological Chemistry.

[24]  W. Hiatt,et al.  Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs. , 2015, The New England journal of medicine.

[25]  P. Arora,et al.  Nonpeptidic foldamers from amino acids: synthesis and characterization of 1,3-substituted triazole oligomers. , 2005, Journal of the American Chemical Society.

[26]  A. Hamilton,et al.  β-Strand mimetic foldamers rigidified through dipolar repulsion. , 2015, Angewandte Chemie.

[27]  A. Hamilton,et al.  Aryl-linked imidazolidin-2-ones as non-peptidic β-strand mimetics. , 2012, Chemical communications.

[28]  J. Wildeman,et al.  Chemistry of sulfonylmethyl isocyanides. 12. Base-induced cycloaddition of sulfonylmethyl isocyanides to carbon,nitrogen double bonds. Synthesis of 1,5-disubstituted and 1,4,5-trisubstituted imidazoles from aldimines and imidoyl chlorides , 1977 .

[29]  E. Settembre,et al.  Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH , 2011, EMBO reports.

[30]  R. Krauss,et al.  Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk. , 2015, Circulation.

[31]  D. Fairlie,et al.  Update 1 of: Beta-strand mimetics. , 2010, Chemical reviews.

[32]  A. Hamilton,et al.  Disrupting protein-protein interactions with non-peptidic, small molecule alpha-helix mimetics. , 2010, Current opinion in chemical biology.

[33]  Wendell A. Lim,et al.  β Strand Peptidomimetics as Potent PDZ Domain Ligands , 2006 .

[34]  R. Hirschmann,et al.  Pyrrolinone-based peptidomimetics. "Let the enzyme or receptor be the judge". , 2011, Accounts of chemical research.

[35]  S. Chandrasekhar,et al.  Oligomers of cis-β-norbornene amino acid: Formation of β-strand mimetics , 2006 .

[36]  P. Bartlett,et al.  Synthesis of amino acid-derived cyclic acyl amidines for use in beta-strand peptidomimetics. , 2007, The Journal of organic chemistry.

[37]  D. Fairlie,et al.  Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potency , 2010, Proceedings of the National Academy of Sciences.

[38]  Andrew J. Wilson,et al.  Inhibition of α-helix-mediated protein-protein interactions using designed molecules. , 2013, Nature chemistry.

[39]  R. Cetin-Atalay,et al.  Application of the Ugi reaction with multiple amino acid-derived components: synthesis and conformational evaluation of piperazine-based minimalist peptidomimetics. , 2015, Organic & biomolecular chemistry.

[40]  Jerome Wielens,et al.  Oncogenic protein interfaces: small molecules, big challenges , 2014, Nature Reviews Cancer.

[41]  Annik Prat,et al.  The biology and therapeutic targeting of the proprotein convertases , 2012, Nature Reviews Drug Discovery.

[42]  T. Ioerger,et al.  Pyrrolinone-pyrrolidine oligomers as universal peptidomimetics. , 2011, Journal of the American Chemical Society.

[43]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[44]  S. Steinhubl,et al.  New Drugs and Technologies , 2014 .

[45]  Gabriel Waksman,et al.  Protein–protein interaction through β-strand addition , 2006 .

[46]  D. Fairlie,et al.  Constraining cyclic peptides to mimic protein structure motifs. , 2014, Angewandte Chemie.